Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience. (gut.bmj.com)

Authors: Maddalena G … Kopetz S Journal: Gut Published: 2026-10-01 DOI: https://doi.org/10.1136/gutjnl-2026-339167